Edmonton, AB--Aurora Cannabis Inc. announced the launch of Valour, a new cannabis cultivar created specifically for veterans in collaboration with the veteran community.
[Image via Cision PR Newswire]
Under the MedReleaf brand, Valour will contribute 5% of net profits to support veteran organizations across Canada. Developed with input from Canadian veterans, Valour features a unique blend of Chemdawg, OG18, and Skunk genetics, offering a premium indica experience with 20-26% THC content. The product is available in 5g and 15g dried flower and prerolls exclusive to veteran Aurora medical patients.
Andre Jerome, Interim SVP of Medical Sales at Aurora Cannabis, expressed the company's commitment to serving veterans, emphasizing that the product is tailored to their needs and preferences. Proceeds from Valour sales, up to $200,000 per year, will fund cash and in-kind donations to veteran-focused organizations and clinics across Canada, including Fondation Le Balancier / The Pendulum Foundation, The Post Traumatic Growth Association, The Valhalla Project, and Thunder Ride Trois-Rivières, among others.
Aurora, headquartered in Edmonton, Alberta, serves medical and consumer markets globally, with a brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, Greybeard, Reliva, KG7, MedReleaf, CanniMed, and Whistler Medical Marijuana Co. Aurora is also a controlling shareholder in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants.
Learn more in this report.